Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Immune thrombocytopenia

Paediatrics and child health · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Intracranial or life-threatening haemorrhage

Neurological change, severe persistent headache, repeated vomiting, respiratory bleeding, haemodynamic compromise or continuous high-volume gastrointestinal, urinary or mucosal bleeding is a haematological emergency.

Action: Use ABCDE, obtain immediate senior paediatric and haematology help, secure blood samples without delaying treatment, and give platelet transfusion with IV immunoglobulin and IV corticosteroid under the emergency protocol while controlling the bleeding source.

Synopsis

Diagnose typical childhood immune thrombocytopenia as an exclusion pattern, grade bleeding rather than treating a platelet number, identify malignancy and systemic mimics, and choose observation, haemostatic support or urgent combined therapy safely.

  • Typical childhood ITP is abrupt petechiae and bruising, sometimes mucosal bleeding, in an otherwise well child after a viral illness.
  • First-line tests are FBC, repeat count if clumping is possible, reticulocytes and expert blood-film review; typical ITP shows isolated thrombocytopenia with no blasts or fragments.
  • Normal examination apart from skin or mucosal bleeding is important: lymphadenopathy, hepatosplenomegaly, bone tenderness or systemic illness is atypical.
  • There is no single diagnostic gold-standard test; ITP is a clinical and laboratory diagnosis of exclusion supported by recovery over time.
  • Management is driven by bleeding severity and context, not the platelet count alone; even a count below 10 × 10^9/L does not automatically require treatment.
  • First-line management for mild or moderate skin-only bleeding is observation, education and planned follow-up rather than medicine.
  • Selected severe bleeding can be treated with short-course prednisolone or IV immunoglobulin after senior discussion; IVIG usually raises the count faster.
  • Life-threatening haemorrhage needs urgent platelet transfusion together with IVIG and IV corticosteroid because transfused platelets are otherwise rapidly destroyed.
  • Avoid aspirin, ibuprofen and other NSAIDs, intramuscular injections and activities with substantial head-injury risk while thrombocytopenia is important.
  • Discharge requires reliable caregivers, open access, written head-injury and bleeding advice, school planning and a repeat FBC and film in 7 to 10 days.

Key red flags

Bone pain, weight loss, fever, failure to thrive, lymphadenopathy or hepatosplenomegaly is atypical for ITP and raises concern for leukaemia or systemic disease.

Anaemia or neutropenia not explained by bleeding, or blasts, fragments or dysplasia on film, requires urgent haematology assessment.

A child under 6 months, gradual onset, lifelong bruising or a family history of thrombocytopenia suggests congenital or inherited disease.

Severe headache, drowsiness, vomiting, seizure or neurological deficit may indicate intracranial haemorrhage even after apparently minor head trauma.

Melaena, haematemesis, macroscopic haematuria, heavy menstrual bleeding causing anaemia or epistaxis persisting despite pressure constitutes significant wet bleeding.

Fever, shock, renal impairment, neurological abnormalities or fragmented red cells suggests sepsis, DIC, HUS or TTP rather than isolated ITP.

Investigation priorities

01
First-line FBC with repeat if necessaryFirst stepFirst line

Confirm true thrombocytopenia and determine whether another blood-cell lineage is affected.

Management branches

Mild or moderate skin bleedingObserve safely

The child is well with typical isolated thrombocytopenia and no important wet bleeding.

  1. Confirm the film and absence of atypical clinical features.
  2. Avoid NSAIDs, intramuscular injections and high-impact activity while risk remains important.
  3. Discharge only with open access, written red flags, school advice and reliable follow-up.
  4. Repeat FBC and film in 7 to 10 days and review the evolving diagnosis.

Key medicines

Prednisolone for selected severe childhood ITPGive 4 mg/kg/day orally in divided doses for 4 days, maximum 200 mg/day, after paediatric consultant discussion; an alternative local regimen is 1 to 2 mg/kg/day for 2 weeks followed by a supervised wean.Avoid or seek specialist alternatives with active serious infection, chickenpox exposure or gastrointestinal bleeding; consider gastric protection, monitor mood, sleep, glucose and blood pressure, and do not extend courses without haematology review because growth and infection toxicity increase.
Intravenous immunoglobulinGive 0.8 to 1 g/kg as a single IV infusion under the local immunoglobulin protocol; a second dose may be required after 24 to 48 hours for ongoing severe or life-threatening bleeding on specialist advice.Check product, renal function, hydration and IgA or prior reaction history; monitor throughout for headache, aseptic meningitis, haemolysis, thrombosis, renal injury and infusion reactions, and follow the nationally governed supply process.
Open full textbook →Answer 2 questions
Sources and review status3 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • Royal Cornwall Childhood ITP Clinical Guideline V5.2Current 2026 UK paediatric assessment, bleeding-led treatment, doses and follow-up.
  • Cambridge University Hospitals ITP Information for ParentsFamily safety advice, activity, school participation, treatments and red flags.
  • University Hospitals Bristol Paediatric Clinical GuidelinesTertiary paediatric source pathway referenced by the current regional guideline.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom